Looking for a specific product?

Make a search for products & suppliers, articles & news.

Bionor Pharma Positioned for Execution of the Kick, the Kill and the Boost Strategy, Aiming Towards a Functional Cure for HIV

Bionor Pharma ASA (OSE: BIONOR) announced today results from the third quarter and first nine months of 2013. 

The Q3 report will be presented by webcast 8 November at 8.30 am CET. Link for registration and access to the webcast: http://www.media-server.com/m/p/zovaz8yn
See further information about the webcast and call numbers below.

Download the Q3 report and Q3 presentation.

 

If you would like to find out more about Bionor Pharma, please visit their website here.

Associated companies:


Related news

Latest news

Visit at Fiskaa from the Chinese ambassador to Norway

The Ambassador of the People’s Republic of China,

New emission rules 2020 - the reliable way to prove compliance

Reducing ship emissions is a top priority for IMO

United Technologies Opens State-of-the-Art Innovation Center, Announces Plan to Create 100 Additional Jobs

Employees working in the building today-

US Army Corps’ first F-10000 Davit

With space onboard Yaquina for davit operations limited, 

Chairman of IACS pinpoints three key themes of the Association’s strategy for the future

Commenting on the publication of the 2017 Annual Review, 

DNV GL launches alternative fuels white paper

For newbuilding vessels,

MINSHIP Shipmanagement boosts digitalization with DNV GL

MINSHIP is optimizing processes as they are managing a growing fleet. 

The fully electric Future of The Fjords has been launched

The new build is 42m long, 

Winner of Norwegian Export Award 2018 Announced

Airthings is the winner of the Norwegian Export Award 2018.